Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin AmyloidosisDavid Adams, Ole B. Suhr, Teresa Coelho et al.|New England Journal of Medicine|2018Cited by 2.9k
Inotersen Treatment for Patients with Hereditary Transthyretin AmyloidosisMerrill D. Benson, Teresa Coelho, Márcia Waddington‐Cruz et al.|New England Journal of Medicine|2018Cited by 1.4k
Research design considerations for chronic pain prevention clinical trialsJennifer S. Gewandter, Gary A. Walco, Robert H. Dworkin et al.|Pain|2015Cited by 143
Na<sub>V</sub>channel variants in patients with painful and nonpainful peripheral neuropathySamir Wadhawan, J. Robinson Singleton, Saumya Pant et al.|Neurology Genetics|2017Cited by 38